Impax Laboratories, Inc. Issues Voluntary, Nationwide Recall for One Lot of Lamotrigine Orally Disinte grating Tablet 200 mg Due to the Potential for 100 mg Blister Cards being Packaged in 200 mg Containers

You are subscribed to Recalls, Market Withdrawals and Safety Alerts for U.S. Food & Drug Administration (FDA). This information has recently been updated and is now available.     Impax Laboratories, Inc. Issues Voluntary, Nationwide Recall for One Lot of…

CDER New August 29, 2016

New and Generic Drug Approvals August 25, 2016 Drug Name Active Ingredient Dosage Form/Route Sponsor Submission Type Codeine Phosphate and Chlorpheniramine Maleate chlorpheniramine maleate; codeine phosphate Tablet, Extended Release;Oral Spriaso Llc Labeling Revision Gleevec imatinib mesylate Tablet;Oral Novartis Efficacy Supplement…